| Literature DB >> 27450014 |
Michael G Whitfield1, Elizabeth M Streicher1, Tania Dolby2, John A Simpson2, Samantha L Sampson1, Paul D Van Helden1, Annelies Van Rie3, Robin M Warren4.
Abstract
Pyrazinamide resistance is largely unknown in the spectrum of drug resistant phenotypes. We summarize data on PZA resistance in clinical isolates from South Africa. PZA DST should be performed when considering its inclusion in treatment of patients with rifampicin-resistant TB or MDR-TB.Entities:
Keywords: DNA sequencing; Mycobacterium tuberculosis; Pyrazinamide; pncA gene
Mesh：
Substances：
Year: 2016 PMID： 27450014 PMCID： PMC4963978 DOI： 10.1016/j.tube.2016.05.003
Source DB: PubMed Journal: Tuberculosis (Edinb) ISSN： 1472-9792 Impact factor: 3.131